nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.553	1	CbGbCtD
Irinotecan—Blood bilirubin abnormal—Riluzole—amyotrophic lateral sclerosis	0.0546	0.21	CcSEcCtD
Irinotecan—BCHE—diaphragm—amyotrophic lateral sclerosis	0.00722	0.157	CbGeAlD
Irinotecan—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.00671	0.0258	CcSEcCtD
Irinotecan—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.00643	0.0247	CcSEcCtD
Irinotecan—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00547	0.021	CcSEcCtD
Irinotecan—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00512	0.0197	CcSEcCtD
Irinotecan—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00487	0.0187	CcSEcCtD
Irinotecan—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00482	0.0185	CcSEcCtD
Irinotecan—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00465	0.0178	CcSEcCtD
Irinotecan—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00465	0.0178	CcSEcCtD
Irinotecan—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00465	0.0178	CcSEcCtD
Irinotecan—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0157	CcSEcCtD
Irinotecan—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0143	CcSEcCtD
Irinotecan—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00359	0.0138	CcSEcCtD
Irinotecan—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0134	CcSEcCtD
Irinotecan—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0134	CcSEcCtD
Irinotecan—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0134	CcSEcCtD
Irinotecan—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0129	CcSEcCtD
Irinotecan—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0126	CcSEcCtD
Irinotecan—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0126	CcSEcCtD
Irinotecan—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0126	CcSEcCtD
Irinotecan—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00297	0.0114	CcSEcCtD
Irinotecan—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00285	0.011	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0105	CcSEcCtD
Irinotecan—Injury—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00998	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00972	CcSEcCtD
Irinotecan—SLC22A3—tongue—amyotrophic lateral sclerosis	0.00249	0.054	CbGeAlD
Irinotecan—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00947	CcSEcCtD
Irinotecan—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00921	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00917	CcSEcCtD
Irinotecan—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00917	CcSEcCtD
Irinotecan—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00872	CcSEcCtD
Irinotecan—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00853	CcSEcCtD
Irinotecan—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00838	CcSEcCtD
Irinotecan—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00835	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00826	CcSEcCtD
Irinotecan—TOP1MT—nervous system—amyotrophic lateral sclerosis	0.00209	0.0455	CbGeAlD
Irinotecan—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00798	CcSEcCtD
Irinotecan—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00777	CcSEcCtD
Irinotecan—TOP1MT—central nervous system—amyotrophic lateral sclerosis	0.00202	0.0438	CbGeAlD
Irinotecan—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00772	CcSEcCtD
Irinotecan—TOP1MT—cerebellum—amyotrophic lateral sclerosis	0.00197	0.0428	CbGeAlD
Irinotecan—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00741	CcSEcCtD
Irinotecan—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00717	CcSEcCtD
Irinotecan—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00711	CcSEcCtD
Irinotecan—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00697	CcSEcCtD
Irinotecan—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00693	CcSEcCtD
Irinotecan—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00689	CcSEcCtD
Irinotecan—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00689	CcSEcCtD
Irinotecan—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00677	CcSEcCtD
Irinotecan—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00646	CcSEcCtD
Irinotecan—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00638	CcSEcCtD
Irinotecan—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00636	CcSEcCtD
Irinotecan—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00634	CcSEcCtD
Irinotecan—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00623	CcSEcCtD
Irinotecan—TOP1MT—brain—amyotrophic lateral sclerosis	0.0016	0.0348	CbGeAlD
Irinotecan—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00589	CcSEcCtD
Irinotecan—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00576	CcSEcCtD
Irinotecan—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00573	CcSEcCtD
Irinotecan—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00572	CcSEcCtD
Irinotecan—Chills—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00569	CcSEcCtD
Irinotecan—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00567	CcSEcCtD
Irinotecan—TOP1—medulla oblongata—amyotrophic lateral sclerosis	0.00147	0.0319	CbGeAlD
Irinotecan—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00561	CcSEcCtD
Irinotecan—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00544	CcSEcCtD
Irinotecan—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00534	CcSEcCtD
Irinotecan—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00531	CcSEcCtD
Irinotecan—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00512	CcSEcCtD
Irinotecan—CES2—medulla oblongata—amyotrophic lateral sclerosis	0.00133	0.029	CbGeAlD
Irinotecan—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0051	CcSEcCtD
Irinotecan—TOP1—spinal cord—amyotrophic lateral sclerosis	0.00131	0.0285	CbGeAlD
Irinotecan—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00498	CcSEcCtD
Irinotecan—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00496	CcSEcCtD
Irinotecan—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00495	CcSEcCtD
Irinotecan—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00494	CcSEcCtD
Irinotecan—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00485	CcSEcCtD
Irinotecan—Cough—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00482	CcSEcCtD
Irinotecan—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00477	CcSEcCtD
Irinotecan—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00465	CcSEcCtD
Irinotecan—SLC22A3—embryo—amyotrophic lateral sclerosis	0.00119	0.0259	CbGeAlD
Irinotecan—CES2—spinal cord—amyotrophic lateral sclerosis	0.00119	0.0258	CbGeAlD
Irinotecan—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00454	CcSEcCtD
Irinotecan—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00451	CcSEcCtD
Irinotecan—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00451	CcSEcCtD
Irinotecan—Infection—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00448	CcSEcCtD
Irinotecan—Shock—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00443	CcSEcCtD
Irinotecan—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00442	CcSEcCtD
Irinotecan—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00441	CcSEcCtD
Irinotecan—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00436	CcSEcCtD
Irinotecan—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0043	CcSEcCtD
Irinotecan—ACHE—medulla oblongata—amyotrophic lateral sclerosis	0.0011	0.0238	CbGeAlD
Irinotecan—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00421	CcSEcCtD
Irinotecan—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00408	CcSEcCtD
Irinotecan—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00405	CcSEcCtD
Irinotecan—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00402	CcSEcCtD
Irinotecan—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00401	CcSEcCtD
Irinotecan—TOP1—cerebellum—amyotrophic lateral sclerosis	0.00104	0.0226	CbGeAlD
Irinotecan—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00397	CcSEcCtD
Irinotecan—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00392	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00389	CcSEcCtD
Irinotecan—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00389	CcSEcCtD
Irinotecan—Pain—Riluzole—amyotrophic lateral sclerosis	0.001	0.00385	CcSEcCtD
Irinotecan—Constipation—Riluzole—amyotrophic lateral sclerosis	0.001	0.00385	CcSEcCtD
Irinotecan—CES2—nervous system—amyotrophic lateral sclerosis	0.001	0.0218	CbGeAlD
Irinotecan—ACHE—spinal cord—amyotrophic lateral sclerosis	0.000979	0.0213	CbGeAlD
Irinotecan—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000967	0.00371	CcSEcCtD
Irinotecan—CES2—central nervous system—amyotrophic lateral sclerosis	0.000965	0.0209	CbGeAlD
Irinotecan—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000959	0.00369	CcSEcCtD
Irinotecan—CES2—cerebellum—amyotrophic lateral sclerosis	0.000943	0.0205	CbGeAlD
Irinotecan—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000928	0.00356	CcSEcCtD
Irinotecan—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000928	0.00356	CcSEcCtD
Irinotecan—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000864	0.00332	CcSEcCtD
Irinotecan—TOP1—brain—amyotrophic lateral sclerosis	0.000844	0.0183	CbGeAlD
Irinotecan—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000842	0.00323	CcSEcCtD
Irinotecan—CES1—nervous system—amyotrophic lateral sclerosis	0.000825	0.0179	CbGeAlD
Irinotecan—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000803	0.00308	CcSEcCtD
Irinotecan—CES1—central nervous system—amyotrophic lateral sclerosis	0.000794	0.0172	CbGeAlD
Irinotecan—ACHE—cerebellum—amyotrophic lateral sclerosis	0.000776	0.0169	CbGeAlD
Irinotecan—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000776	0.00298	CcSEcCtD
Irinotecan—BCHE—brainstem—amyotrophic lateral sclerosis	0.000774	0.0168	CbGeAlD
Irinotecan—CES2—brain—amyotrophic lateral sclerosis	0.000766	0.0166	CbGeAlD
Irinotecan—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000746	0.00287	CcSEcCtD
Irinotecan—Rash—Riluzole—amyotrophic lateral sclerosis	0.00074	0.00284	CcSEcCtD
Irinotecan—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000739	0.00284	CcSEcCtD
Irinotecan—Headache—Riluzole—amyotrophic lateral sclerosis	0.000735	0.00282	CcSEcCtD
Irinotecan—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000697	0.00268	CcSEcCtD
Irinotecan—ACHE—brain—amyotrophic lateral sclerosis	0.000631	0.0137	CbGeAlD
Irinotecan—CES1—brain—amyotrophic lateral sclerosis	0.000631	0.0137	CbGeAlD
Irinotecan—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.000573	0.0124	CbGeAlD
Irinotecan—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.000551	0.012	CbGeAlD
Irinotecan—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.00054	0.0117	CbGeAlD
Irinotecan—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000522	0.0113	CbGeAlD
Irinotecan—BCHE—spinal cord—amyotrophic lateral sclerosis	0.000481	0.0104	CbGeAlD
Irinotecan—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000465	0.0101	CbGeAlD
Irinotecan—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.000446	0.00967	CbGeAlD
Irinotecan—ALB—brain—amyotrophic lateral sclerosis	0.000438	0.00952	CbGeAlD
Irinotecan—SLC22A3—brain—amyotrophic lateral sclerosis	0.000438	0.0095	CbGeAlD
Irinotecan—BCHE—nervous system—amyotrophic lateral sclerosis	0.000406	0.00881	CbGeAlD
Irinotecan—ABCB1—embryo—amyotrophic lateral sclerosis	0.000403	0.00874	CbGeAlD
Irinotecan—BCHE—central nervous system—amyotrophic lateral sclerosis	0.00039	0.00848	CbGeAlD
Irinotecan—BCHE—cerebellum—amyotrophic lateral sclerosis	0.000382	0.00829	CbGeAlD
Irinotecan—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000369	0.00801	CbGeAlD
Irinotecan—ABCC1—brain—amyotrophic lateral sclerosis	0.000362	0.00786	CbGeAlD
Irinotecan—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000362	0.00785	CbGeAlD
Irinotecan—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000348	0.00756	CbGeAlD
Irinotecan—BCHE—brain—amyotrophic lateral sclerosis	0.00031	0.00673	CbGeAlD
Irinotecan—ABCG2—brain—amyotrophic lateral sclerosis	0.0003	0.0065	CbGeAlD
Irinotecan—CYP2B6—brain—amyotrophic lateral sclerosis	0.000276	0.006	CbGeAlD
Irinotecan—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000273	0.00593	CbGeAlD
Irinotecan—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000263	0.00571	CbGeAlD
Irinotecan—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000257	0.00558	CbGeAlD
Irinotecan—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000229	0.00498	CbGeAlD
Irinotecan—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000193	0.0042	CbGeAlD
Irinotecan—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000186	0.00404	CbGeAlD
Irinotecan—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000182	0.00395	CbGeAlD
Irinotecan—ABCB1—brain—amyotrophic lateral sclerosis	0.000148	0.00321	CbGeAlD
Irinotecan—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	9.73e-05	0.000694	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	9.73e-05	0.000694	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	9.71e-05	0.000692	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—FIG4—amyotrophic lateral sclerosis	9.66e-05	0.000689	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	9.64e-05	0.000687	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	9.64e-05	0.000687	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	9.61e-05	0.000685	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	9.45e-05	0.000674	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.4e-05	0.00067	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	9.34e-05	0.000666	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	9.34e-05	0.000665	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	9.33e-05	0.000665	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.32e-05	0.000664	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.32e-05	0.000664	CbGpPWpGaD
Irinotecan—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.31e-05	0.000663	CbGpPWpGaD
Irinotecan—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.18e-05	0.000654	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.17e-05	0.000653	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	9.17e-05	0.000653	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—FIG4—amyotrophic lateral sclerosis	9.17e-05	0.000653	CbGpPWpGaD
Irinotecan—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.1e-05	0.000648	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	9.06e-05	0.000646	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	9.03e-05	0.000644	CbGpPWpGaD
Irinotecan—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.97e-05	0.00064	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.93e-05	0.000637	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	8.9e-05	0.000634	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.84e-05	0.00063	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—FIG4—amyotrophic lateral sclerosis	8.84e-05	0.00063	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	8.82e-05	0.000629	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.74e-05	0.000623	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—DAO—amyotrophic lateral sclerosis	8.74e-05	0.000623	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.63e-05	0.000615	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.63e-05	0.000615	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	8.62e-05	0.000614	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	8.6e-05	0.000613	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	8.51e-05	0.000607	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PLB1—amyotrophic lateral sclerosis	8.41e-05	0.0006	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	8.4e-05	0.000599	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.3e-05	0.000592	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—DAO—amyotrophic lateral sclerosis	8.29e-05	0.000591	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—DAO—amyotrophic lateral sclerosis	8.29e-05	0.000591	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.27e-05	0.00059	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.2e-05	0.000584	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	8e-05	0.00057	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	7.99e-05	0.00057	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	7.79e-05	0.000556	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	7.78e-05	0.000554	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	7.78e-05	0.000554	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GSR—amyotrophic lateral sclerosis	7.76e-05	0.000553	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	7.73e-05	0.000551	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	7.71e-05	0.00055	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.69e-05	0.000548	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	7.6e-05	0.000542	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	7.51e-05	0.000536	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.39e-05	0.000526	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	7.23e-05	0.000516	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	7.23e-05	0.000515	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	7.21e-05	0.000514	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	7.13e-05	0.000508	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	7.13e-05	0.000508	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	7.03e-05	0.000501	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	7e-05	0.000499	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.97e-05	0.000497	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	6.97e-05	0.000497	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	6.97e-05	0.000497	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	6.97e-05	0.000497	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	6.94e-05	0.000495	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	6.9e-05	0.000492	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PLB1—amyotrophic lateral sclerosis	6.62e-05	0.000472	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	6.57e-05	0.000468	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	6.52e-05	0.000465	CbGpPWpGaD
Irinotecan—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	6.45e-05	0.00046	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	6.38e-05	0.000454	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CHAT—amyotrophic lateral sclerosis	6.37e-05	0.000454	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.28e-05	0.000448	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PLB1—amyotrophic lateral sclerosis	6.28e-05	0.000448	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.26e-05	0.000446	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	6.15e-05	0.000438	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GSR—amyotrophic lateral sclerosis	6.11e-05	0.000436	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	6.08e-05	0.000433	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.06e-05	0.000432	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.06e-05	0.000432	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	6.03e-05	0.00043	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	6e-05	0.000428	CbGpPWpGaD
Irinotecan—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	6e-05	0.000428	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.93e-05	0.000423	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.92e-05	0.000422	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	5.91e-05	0.000421	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	5.9e-05	0.00042	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	5.89e-05	0.00042	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	5.8e-05	0.000413	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	5.8e-05	0.000413	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GSR—amyotrophic lateral sclerosis	5.8e-05	0.000413	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	5.76e-05	0.00041	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	5.7e-05	0.000406	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	5.62e-05	0.000401	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.6e-05	0.000399	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	5.59e-05	0.000399	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	5.57e-05	0.000397	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.56e-05	0.000397	CbGpPWpGaD
Irinotecan—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	5.49e-05	0.000391	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.48e-05	0.000391	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	5.45e-05	0.000389	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.33e-05	0.00038	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.32e-05	0.000379	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.32e-05	0.000379	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	5.31e-05	0.000379	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	5.28e-05	0.000377	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.28e-05	0.000376	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	5.26e-05	0.000375	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	5.26e-05	0.000375	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	5.22e-05	0.000372	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	5.2e-05	0.000371	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	5.16e-05	0.000368	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.1e-05	0.000364	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.09e-05	0.000363	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	5.04e-05	0.000359	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CHAT—amyotrophic lateral sclerosis	5.02e-05	0.000358	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.96e-05	0.000354	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	4.92e-05	0.000351	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	4.88e-05	0.000348	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.84e-05	0.000345	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.81e-05	0.000343	CbGpPWpGaD
Irinotecan—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	4.8e-05	0.000342	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.76e-05	0.000339	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.76e-05	0.000339	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.74e-05	0.000338	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.66e-05	0.000332	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.66e-05	0.000332	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	4.63e-05	0.00033	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.59e-05	0.000327	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.58e-05	0.000326	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	4.48e-05	0.000319	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.47e-05	0.000319	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.47e-05	0.000319	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.36e-05	0.000311	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.34e-05	0.00031	CbGpPWpGaD
Irinotecan—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	4.34e-05	0.000309	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.23e-05	0.000301	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	4.21e-05	0.0003	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.19e-05	0.000299	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.17e-05	0.000297	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.16e-05	0.000296	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.08e-05	0.000291	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.04e-05	0.000288	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	4.01e-05	0.000286	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	4e-05	0.000285	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.98e-05	0.000284	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	3.94e-05	0.000281	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.91e-05	0.000279	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	3.82e-05	0.000272	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	3.8e-05	0.000271	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	3.61e-05	0.000257	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	3.52e-05	0.000251	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.43e-05	0.000244	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.39e-05	0.000241	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	3.36e-05	0.00024	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	3.29e-05	0.000234	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	3.27e-05	0.000233	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	3.27e-05	0.000233	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.24e-05	0.000231	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.24e-05	0.000231	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.15e-05	0.000224	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.14e-05	0.000224	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.04e-05	0.000216	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.04e-05	0.000216	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	3.04e-05	0.000216	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.98e-05	0.000212	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.96e-05	0.000211	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.96e-05	0.000211	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	2.92e-05	0.000208	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	2.89e-05	0.000206	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.88e-05	0.000205	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	2.88e-05	0.000205	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.87e-05	0.000205	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.8e-05	0.0002	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.76e-05	0.000197	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.76e-05	0.000196	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.73e-05	0.000194	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.7e-05	0.000192	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	2.66e-05	0.00019	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.62e-05	0.000186	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	2.59e-05	0.000185	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	2.59e-05	0.000185	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.58e-05	0.000184	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.56e-05	0.000182	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.56e-05	0.000182	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	2.49e-05	0.000178	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.48e-05	0.000177	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.47e-05	0.000176	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.41e-05	0.000172	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.35e-05	0.000168	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.35e-05	0.000168	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.34e-05	0.000167	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.34e-05	0.000167	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.27e-05	0.000162	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.27e-05	0.000162	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	2.23e-05	0.000159	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.21e-05	0.000158	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.18e-05	0.000156	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.17e-05	0.000155	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.15e-05	0.000154	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.15e-05	0.000153	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.06e-05	0.000147	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—APOE—amyotrophic lateral sclerosis	2.04e-05	0.000145	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2e-05	0.000142	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.98e-05	0.000141	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.95e-05	0.000139	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.93e-05	0.000138	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—APOE—amyotrophic lateral sclerosis	1.93e-05	0.000138	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	1.87e-05	0.000133	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	1.82e-05	0.00013	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.78e-05	0.000127	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.77e-05	0.000127	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	1.77e-05	0.000126	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	1.64e-05	0.000117	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.64e-05	0.000117	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	1.63e-05	0.000116	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.59e-05	0.000113	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.56e-05	0.000111	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.56e-05	0.000111	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	1.53e-05	0.000109	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.46e-05	0.000104	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000102	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.4e-05	9.96e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.35e-05	9.61e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.35e-05	9.59e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.34e-05	9.55e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.33e-05	9.45e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.33e-05	9.45e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.28e-05	9.11e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.25e-05	8.89e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	8.78e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.21e-05	8.66e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	1.2e-05	8.58e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.18e-05	8.38e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.17e-05	8.37e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.12e-05	8.02e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.11e-05	7.95e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	7.69e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.02e-05	7.26e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.01e-05	7.22e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	8.88e-06	6.33e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.25e-06	5.88e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.06e-06	5.75e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.23e-06	5.16e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.94e-06	4.95e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.65e-06	4.74e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.08e-06	4.34e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.47e-06	3.9e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.75e-06	2.67e-05	CbGpPWpGaD
